Search - tctmd.com

Displaying 41 - 60 of 154

Sort: Relevancy | Date

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

New-Generation Watchman FLX Maintains Good Results Through 2 Years

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

July 28, 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This is Hard’

News Conference News TVT 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

July 27, 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

July 26, 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presentation TVT 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

July 22, 2021

Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices

Presentation TVT 2021

Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices

Presenter: JoAnn Lindenfeld

July 22, 2021

How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices

Presentation TVT 2021

How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices

Presenter: Susan M. Joseph

July 22, 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

July 22, 2021

TMVR Patient Eligibility and Clinical Trial Considerations in the Post-COAPT Era (MVARC II)

Presentation TVT 2021

TMVR Patient Eligibility and Clinical Trial Considerations in the Post-COAPT Era (MVARC II)

Presenter: Gregg Stone

July 21, 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Presentation TVT 2021

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Presenter: Saibal Kar

July 21, 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

July 20, 2021

Clinical Trial Considerations for Bicuspid Aortic Valve for Disease: What Should the Next Study Look Like?

Presentation TVT 2021

Clinical Trial Considerations for Bicuspid Aortic Valve for Disease: What Should the Next Study Look Like?

Presenter: David Cohen

July 20, 2021

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Presentation TVT 2021

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Presenter: Gennaro Giustino

July 20, 2021

Predictors of Reduction in Mitral Regurgitation by the MitraClip - Durable, Transient, or Failures in the COAPT Trial

Presentation TVT 2021

Predictors of Reduction in Mitral Regurgitation by the MitraClip - Durable, Transient, or Failures in the COAPT Trial

Presenter: Scott Lim

July 20, 2021

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

Stroke in TAVR Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

June 25, 2020

Device Explants After TAVR Rare but Risky

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

June 24, 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.